FDA Inspection
Dextrum Laboratories Inc.Dextrum Laboratories Inc. – FDA Inspection, Aug 29, 2024
Record Details
This FDA Inspection record concerns Dextrum Laboratories Inc., with an inspection on August 29, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ccff1439-20fc-405e-8573-0ec3d6b2657a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1249319
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.84(d)(2)Component written specification
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.110(a)Written in-process control procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dextrum Laboratories Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dextrum Laboratories Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.